Cancerversary 4 Years – Jeff Bernstein
“Normal may seem ordinary. But once it is gone you just want it back. A normal life is truly extraordinary.”
Immunotherapy: Game Changing Cancer Treatments
Two recent articles summarize the promise that immunotherapy provides for the future of cancer treatment. Immunotherapy refers to treatments that aid your own immune system in fighting cancer cells. The first, from U.S. News [...]
Institute of Medicine Report Findings on Diagnostic Error
A recent report from the Institute of Medicine (IOM), Improving Diagnosis in Healthcare, outlines findings on the state of diagnostic error in our healthcare system. A follow-up to the 2000 landmark study, To Err [...]
Logistic Toxicity: A Concern for Cancer Patients and Caregivers
A cancer diagnosis is overwhelming for both the patient and their caregivers. There is so much to absorb: the emotions, the drastic change in priorities and lifestyle, the treatments required, the financial burden. In [...]
Memorial Sloan Kettering Cancer Center Announces Innovative Basket Study
Memorial Sloan Kettering Cancer Center (MSKCC) recently announced results from a "basket study," an innovative clinical trial design that studies response to drugs based on specific mutations in patients' tumors rather than where the cancer originated.The [...]
August 2015 Newsletter – Special Celebration Issue
As the summer winds down, we are pleased to share with you our special Celebration Issue! We have a great deal to celebrate in 2015. What better image to illustrate a celebration than fireworks exploding in [...]
Mutational Analysis of GISTs: How, When, and Why
Please join us for an afternoon of learning about the importance of and the science behind mutational testing with pathologist and GIST specialist, Dr. Christopher Corless of Portland's Oregon Health and Science University. This [...]
Need for Extended Adjuvant Treatment to Prevent Recurrence in GIST May Be Underestimated
A recent study in JAMA Oncology found that patients who undergo primary GIST resection might not receive the optimal recommended duration of adjuvant therapy, which can impact their recurrence-free survival (RFS). The study was [...]
Update on Potential Treatments for Imatinib-Resistant GIST
In a recent article entitled "Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions" published online in Springer for Research and Development, LRG Research Team member Sebastian Bauer [...]
GIST: Avances en Diagnostico y Tratamiento
GIST Avances en Diagnostico y Tratamiento presentación del Dr. Marcelo Garrido Salvo, July 23, 2015.